Trial intelligence / Profile preview

Pilot trial of Imatinib (Glivec) in acute ischaemic stroke undergoing intravenous thrombolysis

2010-019014-25Phase 2Active

Sponsor
Karolinska University Hospital
Start
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of imatinib in brain infarction (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Safety and tolerability (serious and non-serious adverse events). Started May 2010; status: active.

02

Drugs

03

Conditions

brain infarction

Beyond the preview

Go deeper on 2010-019014-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019014-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call